RELX PLC (RELX) operates as a global provider of information-based analytics and decision tools for professional and business customers.
The company’s products are generally sold through dedicated sales forces direct to customers and are priced on a subscription or transactional basis, often under multi-year contracts, and are predominantly delivered in electronic format. RELX serves customers in more than 180 countries and territories and has offices in about 40 countries.
Segments
The compa...
RELX PLC (RELX) operates as a global provider of information-based analytics and decision tools for professional and business customers.
The company’s products are generally sold through dedicated sales forces direct to customers and are priced on a subscription or transactional basis, often under multi-year contracts, and are predominantly delivered in electronic format. RELX serves customers in more than 180 countries and territories and has offices in about 40 countries.
Segments
The company operates in four major market segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions.
Risk segment
Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency.
LexisNexis Risk Solutions, headquartered in Alpharetta, Georgia, has principal operations in California, Florida, Illinois, New York and Ohio in North America, as well as London and Paris in Europe, São Paulo in Latin America and Beijing and Singapore in the Asia Pacific. It serves customers in more than 180 countries.
LexisNexis Risk Solutions comprises the following market-facing industry/sector verticals: Business Services, Insurance, Specialised Industry Data Services, and Government Solutions.
Business Services
Business Services enables global financial transparency and inclusion by providing holistic and actionable insights for all risk and compliance segments. The company helps customers address some of today’s greatest societal challenges, including identifying fraud, cybercrime, bribery, corruption, human trafficking, economic sanctions, global terrorism, and abusive practices. The combination of the company’s proprietary insights and advanced analytics powered by Artificial Intelligence (AI) and Machine Learning (ML) delivers actionable intelligence to customers to help improve decisions and operational efficiency.
The cornerstone of the company’s growth strategy in business services is maximizing penetration in its markets across its customers’ workflows and through international expansion.
In 2024, Business Services further established itself as a platform provider with industry analyst recognition for both its Dynamic Decision Platform and Risk Narrative platform. Across solutions the company was recognized as leaders in 19 industry analyst reports, including Juniper Research for both Anti-Money Laundering Systems and Global Fraud Detection and Prevention in Banking, Chartis Research for Watchlist and Adverse Media Monitoring Solutions, Javelin for Authentication and Identity-Proofing, Forrester Research for Enterprise Fraud Management Solutions and Celent for Watchlist Screening.
Business Services has introduced a number of product enhancements and launches, such as in the U.K. with ThreatMetrix Payment Defense, a ML model designed to tackle the growing risk of scams across financial industries. Business Services UK modernized its portfolio of tracing, identity authentication and identity data consolidation solutions. The company launched three new Firco Continuity modules that focus on reducing false positive alerts and time spent on manual alert reviews and enabling customers to test configurations in a secure environment.
Insurance
Insurance provides comprehensive data, analytics and decision tools for personal auto and home, commercial and life insurance carriers to improve critical aspects of their business. Information solutions help insurers assess risks; improve customer acquisition, experience, and retention; identify and intercept fraud; increase efficiency in pricing and underwriting insurance policies; and settle claims in the U.S. and other key markets. Industry-leading products provide real-time information on policy holders, identify insurance coverage details and lapses in coverage, and give insurers access to vehicle and behavior-centric data, standardized across automakers for the underwriting and claims processes. Innovative decision tools seamlessly integrate into an insurer’s workflow and are delivered through a single point of access within an insurer’s infrastructure.
Insurance solutions drive more consistency and efficiency in claims, providing data and decisions for challenging total losses at first notice of loss and throughout the claim life cycle. Insurance solutions provide comprehensive interior and exterior data for home and commercial property insurers and offers AI-enabled insights to fast-track decision-making for new business or renewal underwriting and claims processes. Life insurers use predictive models, public and motor vehicle records to better understand mortality risk, reduce misrepresentation and make life insurance more accessible. In 2024, the company integrated and innovated Human API’s proprietary, consumer-driven health data platform and launched evidence-based ordering of behavioral data, enabling more efficient underwriting processes for life insurers.
Specialised Industry Data Services
Specialised Industry Data Services provides critical business intelligence, data, software and analytics solutions to professionals in many of the world’s largest industries. These solutions include ICIS, an independent source of data and intelligence for the global commodities, chemicals and energy markets; Cirium, the aviation analytics company; Brightmine, a compliance, benchmarking and pay-equity data and analytics business driving global HR topics; and Nextens, a provider of workflow solutions, content, and analytics for tax professionals.
Government
Government, representing just over 5% of revenue, has helped the U.S. agencies shift from identity verification to authentication to confront fraud, waste, and abuse. Front-end identity authentication is central to how the government dispenses hundreds of billions of dollars in entitlements, stimulus, benefits, and contracts to people and businesses.
LexisNexis Accurint AI Insights is a new, first-to-market AI solution for public safety, designed specifically for law enforcement. This advanced tool automates crime trend identification, providing agencies with rapid analysis and actionable intelligence. By enabling proactive responses to emerging threats, Accurint AI Insights streamlines investigative processes and enhances decision-making. The platform offers immediate access to identity and authentication analytics, combining advanced AI with extensive data expertise to support public safety agencies in protecting communities with data-driven insights.
Fraud and Identity Management Portfolio
The company provides digital, physical, device and behavioural risk signals to help organisations better assess consumers, prevent fraudulent transactions, improve operational efficiencies and protect accounts while minimising friction for trusted users. Fraud and Identity launched additional behavioural biometrics capabilities in 2023 with the completed integration of BehavioSec.
LexisNexis Risk Solutions
Financial Crime Compliance Portfolio
The company’s integrated financial crime compliance offerings deliver comprehensive solutions for addressing financial crime risk. Business Services released three new modules within Firco Continuity. These include the Automated Hit Qualifier, which enables automatic remediation of recurring false positive hits across transactions; the Entity Resolution Filter, which reduces the number of alerts needing manual review and accelerates the handling of true alerts; and the Simulation Manager, which allows clients to test and refine customised configurations in a secure sandbox environment.
Platforms Portfolio
The company’s platforms provide unified anti-money laundering, fraud, compliance and risk management capabilities with simple integration for customers. The company launched several new apps and capabilities to improve the company’s guided image capture for document authentication on RiskNarrative. Platforms added a Model Performance Report to its Dynamic Decisioning Platform, which enables customers to compare the performance of different ThreatMetrix models. The platform generates Model Governance documentation automatically to help ensure transparency and regulatory compliance.
LexisNexis Claims Compass
The company’s data analytics platform delivers LexisNexis Claims Datafill, VINsights, Carrier Discovery, Claims Clarity and LexisNexis Police Records solutions directly into insurer workflows to improve the claims process from first notice of loss, triage, investigation and resolution, through recovery.
LexisNexis Total Property Understanding
The company’s complete property risk assessment solution helps home insurance underwriters more easily identify properties with risk or coverage opportunities and survey those priority properties using consumer-friendly, configurable AI-driven property assessment technology that delivers actionable insights into the underwriting workflow.
Business Model, Distribution Channels and Competition
The company sells its products direct-to-client, with pricing based on subscription or transactional with volumetric elements. It also utilizes a robust partner distribution channel.
Specialized Industry Data Services competes with a number of information providers on a service by service basis, including S&P Global Platts and Thomson Reuters.
LexisNexis Risk Classifier
LexisNexis Risk Classifier is an advanced risk assessment solution used by the U.S. life insurance companies helps historically underserved communities secure the policies they need.
The LexisNexis Risk Classifier solution provides the U.S. life insurance companies a robust view of applicants using electronic data to accelerate underwriting, triage more effectively and make better informed accelerated underwriting decisions, while eliminating invasive application requirements that deter individuals from applying or following through. LexisNexis Risk Solutions utilizes attributes from public records, driving history and credit distilled into a numeric risk score using advanced algorithms that corresponds to a proposed insured’s mortality risk profile. The solution’s flexibility means simpler cases are fast-tracked and complex cases obtain experienced underwriters’ attention.
LexisNexis Digital Identity Network
LexisNexis Digital Identity Network is a crowd-sourced contributory network of over 109bn global annual transactions and shared fraud intelligence. It is trusted by leading brands across the world, including all ten of the U.K.’s biggest banks.
Scientific, Technical & Medical segment
Scientific, Technical & Medical delivers insights that help universities, research institutions, governments and funders achieve their strategic goals. The company helps researchers discover and share knowledge, collaborate, and accelerate innovation. The company helps librarians provide trusted, high-quality information to their universities. The company helps innovators transform the latest knowledge into new products. The company helps health professionals improve patient care, and educators train the next generation of doctors and nurses.
Scientific, Technical & Medical helps researchers and healthcare professionals’ advance science and improve health outcomes by combining high-quality scientific and medical information and trusted data sets with leading technology to deliver analytical tools that facilitate insights and critical decision-making.
Elsevier is headquartered in Amsterdam, with principal sites in Boston, New York, Philadelphia, and St. Louis in North America; London, Oxford, Frankfurt, Munich, Madrid, and Paris in Europe; Beijing, Shanghai, Chennai, Delhi, Chatswood, Singapore, and Tokyo in the Asia Pacific, and Rio de Janeiro in South America. It serves customers in over 170 countries and territories.
Elsevier’s customers are scientists, research leaders, librarians, medical researchers, doctors, nurses, allied health professionals and students, as well as hospitals, academic and research institutions, health insurers, managed healthcare organizations, research-intensive corporations, funders, and governments.
Elsevier’s services across Academic & Government, Corporate and Health markets focus on: Databases, Tools and Electronic reference; Primary Research; and Print products. Databases, Tools and Electronic Reference, together with Corporate Primary Research with Academic & Government Primary Research accounting for a similar amount, all in electronic format.
Databases, Tools & Electronic Reference
Elsevier’s databases, tools and electronic reference products help customers and users solve complex problems and make critical decisions, and it is enhancing these capabilities with generative AI across all the company’s business areas. Solutions include Engineering Village, Interfolio, Pure, SciVal, and Scopus in Academic & Government; Embase, Reaxys, and SciBite in Corporate; and ClinicalKey, ClinicalPath, Complete Anatomy, HESI, Osmosis, Shadow Health, and Sherpath for Health.
Elsevier’s research intelligence portfolio of products combines quality, curated content and extensive data sets with responsible AI and large language model (LLM) technology to help researchers, academic leaders, policymakers, funders and R&D-led corporations to generate insights, set and implement research strategies and make decisions with confidence.
This portfolio integrates with and enhances the systems institutions rely on, with interoperability driven by Application Programming Interface technologies (APIs). In early 2024, Elsevier launched Scopus AI, a generative AI-enhanced research tool integrated into the Scopus platform to help academics and researchers get deeper research insights faster, navigate and understand different disciplines more easily and support interdisciplinary collaboration.
For Corporate R&D, SciBite tools and the data as a service offering follow Elsevier’s ontology-led approach and support corporate R&D customers in extracting scientific insights from vast amounts of unstructured text and databases. In 2024 Elsevier launched SciBite Chat, a new AI-powered tool built atop SciBite Search, SciBite’s award-winning platform, combining semantic search information retrieval with LLMs to interpret natural language questions and generate answers for researchers in Life Sciences.
In Health, Elsevier’s clinical solutions include digital solutions for doctors, nurses, care teams and patients. Its clinical reference platform, Clinical Key, helps doctors, nurses and students find clinically-relevant answers through a range of trusted content across specialties. This includes Elsevier’s vast collection of medical reference content, including over 2,400 clinical overviews, over 6.6m images and over 114,000 medical videos in one integrated platform. ClinicalPath Oncology presents evidence-based oncology pathways embedded in the clinical workflow, and the associated analytics, to help oncology care teams make consistent, well-informed decisions for high quality care. In 2024, Elsevier launched ClinicalKey AI, which combines the latest and most trusted medical content with generative AI to help clinicians at the point of care.
Elsevier also serves students of medicine, nursing, and allied health professions. Sherpath, an adaptive teaching and learning solution, provides personalized learning paths at over 700 institutions, supporting more than 300,000 course enrolments, while ClinicalKey Student is used in over 360 medical schools globally. In 2024, Elsevier introduced Sherpath AI, a generative AI chat tool designed specifically for nursing students. The tool integrates Elsevier's nursing education content with advanced generative AI, helping students and nurse educators navigate courses, exam preparation, and the transition into clinical practice. In 2024, Elsevier also launched CompleteHeartX, the world's first heart education experience in spatial computing. The product provides healthcare learners with a unique experience to learn about the heart through interactive 3D models, images and simulations on Apple Vision Pro.
In commercial healthcare, identity, claims and provider data is combined with patient information to assist healthcare providers, pharmacies and insurers in delivering improved health outcomes, ensuring accurate and complete provider data and regulatory compliance.
In electronic reference, Elsevier provides authoritative reference content to scientific, technical and medical professionals. Flagship titles include Gray’s Anatomy, Nelson’s Pediatrics, and Netter’s Atlas of Human Anatomy.
Print includes primary research and reference content in print format and some print-based commercial marketing services in pharmaceutical & life science promotion.
Primary Research
Elsevier helps researchers validate, improve and disseminate their scientific findings through its more than 3,000 journals, enhancing the record of scientific knowledge by applying highest standards of quality and ensuring trusted research can be accessed, shared and built upon. Elsevier journals are the foremost publications in their field, including flagship families of journals like CellPress and The Lancet. Research content is distributed and accessed via ScienceDirect, the world’s largest platform dedicated to peer-reviewed primary scientific and medical research.
In 2024, Elsevier received more than 3.5m article submissions, which were rigorously reviewed by the company’s in-house editorial teams in collaboration with 36,000 editors and 1.7 million expert reviewers around the world. The result is over 720,000 articles enhanced, indexed, certified, published and promoted following peer review, with the global scientific community accessing articles over 2.4bn times across its journal platforms. Elsevier published over 250,000 open access articles, a year-on-year increase of over 30%, and launched 50 new fully open access journals, bringing that total to over 890.
Elsevier has also invested in other research solutions, such as SSRN, an open access online preprint community where researchers post early-stage research, Scopus Author Profiles showing preprints to provide an early view into a researcher’s focus areas and Digital Commons helping academic libraries showcase and share their institutions’ research via institutional repositories for greatest impact.
Print
Print includes primary research and reference content in print format and some print-based commercial marketing services in pharmaceutical & life science promotion.
Strategic Priorities
Elsevier’s strategic priorities are to help the company’s customers solve critical and complex problems, by expanding content quality, coverage and utility; combining content with analytics and technology to build integrated solutions and decision tools that utilize advanced Machine Learning (ML) and Artificial Intelligence to improve productivity and outcomes, and enable insights underpinning critical decisions, benchmarking and evaluation.
In Databases, Tools and Electronic Reference, Elsevier is applying advanced linking capabilities to its vast research information, patent, research grant, drug information and medical claims data sets to develop products that help the company’s academic & government, corporate and health customers make the right decisions based on their needs. For example, within Health, Elsevier is developing clinical decision support applications using cognitive technologies and content repositories, leveraging its proprietary healthcare knowledge graph. These applications will enhance delivery of content in care, helping health professionals make more accurate diagnoses, ensure appropriate care delivery and save lives.
In Primary Research, Elsevier’s priority is to support researchers by finding a home for every sound science article submitted, and providing choice in payment model, quality tier, and scientific discipline. The company intends to deliver above industry average journal and article quality, at below average article download and publishing cost, leveraging its scale and expertise. Elsevier works with customers to help them reach their research goals through excellence in content, service and value. Elsevier is building on its premium brands, enhancing quality through peer review, and increasing article volume through new journal launches, the expansion of open access journals and growth from emerging markets; and broadening the range and quality of insights across research solutions.
The company continues to improve customer experience while driving operational efficiency and effectiveness; and collaborate to advance open science, inclusive research and inclusive health and support the UN SDGs, through its business and the Elsevier Foundation.
Business Model, Distribution Channels and Competition
In Databases, Tools and Electronic Reference, solutions like Scopus, ClinicalKey, and Reaxys, are generally sold direct to institutional, healthcare and corporate customers through a global sales force. Reference and educational content are sold directly to institutions and individuals and accessed on Elsevier platforms.
In Primary Research, science and medical research is distributed via the ScienceDirect platform, supported by two separate payment models to suit author preferences: pay-to-read articles funded by payments for reading made by individuals or institutions; and pay to publish funded by payments for publishing, made by authors, their institution or funding bodies. Elsevier offers a range of pay to read and pay to publish options, both subscription-based and transactional, to fit the diverse needs of institutions, funders, and researchers worldwide. As of 2024, Elsevier served over 3,600 institutions worldwide with transformative deals that support open access to research. Nearly all of Elsevier's over 3,000 journals enable open access publishing, with more than 890 dedicated author pays journals, the largest portfolio of open access titles in the industry.
Elsevier is a founding and driving partner of Research4Life, a United Nations initiative, providing free or low-cost access to research for publicly funded institutions in the world’s least resourced countries. Over 11,500 institutions in 125 countries participate. Print books are sold through retailers, wholesalers and directly to users.
Competition within science and medical reference content is generally on a title-by-title and product-by-product basis, typically with learned society publishers and professional information providers, such as Springer Nature, Clarivate, and Wolters Kluwer.
ClinicalKey AI
ClinicalKey AI is a conversational search tool to support clinical decisions.
Launched in February 2024, ClinicalKey AI is Elsevier’s new clinical decision support tool designed specifically for clinicians and powered by responsible generative artificial intelligence. Combining generative AI with the latest evidence-based medical content allows clinicians at the point of care to quickly and easily extract precise knowledge from a vast body of clinical information to help ensure their decisions are based on the latest evidence.
Pure
Pure is one of the world's leading commercially available Research Information Management Systems. Pure integrates a wide range of research databases and research outputs to provide analysis that enhances decision-making, enables showcasing and collaboration, and evidence-based execution of research strategy.
Legal segment
This segment helps lawyers win cases, manages their work more efficiently, serves their clients better, and grows their practices by deploying advanced analytics and latest, cutting-edge technology, including artificial intelligence (AI). The company assists corporations in better understanding their markets and monitoring relevant news. The company partners with leading global associations and customers to help advance the Rule of Law across the world.
Legal helps its customers improve decision-making, achieve better outcomes and increase productivity by providing tools that combine legal, regulatory and business information with powerful analytics.
LexisNexis Legal & Professional is headquartered in New York and has further principal operations in Dayton, Raleigh, and Toronto in North America, London and Paris in Europe, and cities in several other countries in Africa and the Asia Pacific. It serves customers in almost 150 countries and territories.
LexisNexis Legal & Professional is organized in market-facing groups, focused on Law Firms & Corporate Legal, Government & Academic, and News & Business markets. Services are delivered primarily in electronic format, with print formats available where there is customer demand. Content and tools are tailored to the specific geographic markets served, supported by global shared services organizations providing platform and product development, operational and distribution services, and other support functions.
Law Firms & Corporate Legal
Law Firms & Corporate Legal, representing over 60% of revenue, provides legal professionals across law firms and corporate legal departments with electronic reference, decision tools, and analytics to help make better informed decisions in the practice of law.
Standard products for legal research and analytics include Lexis, Lexis+, and Lexis+ AI, which provide statutes and case law combined with analysis and expert commentaries from secondary sources, such as Matthew Bender, and incorporate the leading citation service, Shepard’s, advising on the continuing relevance of case law precedents.
Lexis+ AI was introduced in the U.S. in 2023 and is a generative AI platform designed to transform legal work. It is built and trained on one of the world’s largest repositories of accurate and exclusive legal content, leveraging an extensive collection of documents and records to provide customers with trusted, comprehensive legal results with unmatched speed and precision and backed by verifiable, citable authority. The new Lexis+ AI technology features conversational search, insightful summarization, uploaded document analysis, and intelligent legal drafting capabilities, all supported by state-of-the-art encryption and privacy technology to keep sensitive data secure.
In 2024, Lexis+ AI adoption grew in the U.S, and it was successfully rolled out across the world. In June 2024, Lexis+ AI was commercially launched to the U.K. and Australia markets. In July, Lexis+ AI was launched in France, with primary sources like case law and secondary doctrinal content like the JurisClasseur. In Canada during September 2024, Lexis+ AI was commercially launched in French, becoming the first comprehensive bilingual Canadian legal generative AI solution available in the country. Lexis + AI U.S. was also launched in Asia, with customers in China, Japan, and Korea.
Lexis+ is the cornerstone of online research and is being rolled out other countries and enhanced in existing countries. All customers in the UK were upgraded to Lexis+ UK in 2024. Lexis+ Ireland was expanded to cover Banking & Financial Services, Commercial, Corporate, Dispute Resolution and Property. In South Africa, the Lexis+ platform was made available to all customer segments in 2024, paving the way for Lexis+ AI in 2025. In New Zealand, Lexis+ was launched in July 2024. In Malaysia, Lexis+ was also launched in July 2024 with Malaysia Legislation Citator, providing reports of legislative instruments and their provisions.
In 2024, LexisNexis continued to broaden the reach of its decision tools and analytics through Lex Machina. Legal Analytics for U.S. federal district courts were expanded to cover findings, remedies and damages for Civil Rights litigation covering First Amendment, Voting, Education, and Housing, as well as Americans with Disabilities Act (ADA) and police action cases. It also released Litigation Footprint in March 2024, which provides the most advanced view of company litigation history for business development, competitive analysis, and case strategy.
In 2024, LexisNexis launched Intelligize+ AI, the next generation of its premier SEC compliance analytics and research platform. The reimagined platform includes generative artificial intelligence driven capabilities and new search technologies that enable users to find, analyze, and compare documents quickly and easily.
LexisNexis expanded legal news coverage with Law360 in 2024, with the launch of Healthcare Authority. In 2024, it also expanded global legal news coverage with the launch of MLex’s Intellectual Property and Artificial Intelligence coverage.
LexisNexis continued to enrich core solutions across global segments in 2024. In July 2024, LexisNexis completed the acquisition of Henchman, a legal tech company that enriches data from Document Management Systems (DMS) for faster document drafting.
LexisNexis also supplies software solutions for legal spend management, matter management, and client engagement. In 2024, LexisNexis launched CounselLink+, a fully integrated Enterprise Legal Management and Contract Lifecycle Management platform, featuring interconnectivity to the LexisNexis portfolio, Practical Guidance templates within the Contract module, and Ask Legal on Microsoft Teams. InterAction+, a customer relationship management solution that unites a business development tool with a modern user experience, continued to build out capabilities into its solution, enabling customers to migrate to its cloud-based offering.
Government & Academic
Government & Academic serves customers across government organizations and law schools.
LexisNexis legal research and analytics tools empower legal professionals across major U.S. federal agencies and state and local government in upholding the rule of law. Products, such as Lexis+, Lexis+ AI and Practical Guidance enable efficient research, while CaseMap helps manage and collaborate on legal cases. LexisNexis Reed Tech also provides patent data and document management services to the U.S. Patent and Trademark Office, with over 50 years of partnership. LexisNexis actively engages with law school users with a focus on product features and research methods, reaching faculty, and students across over 210 U.S. law schools in 2024. Through national marketing and in-person programs, LexisNexis helps students and faculty build search dexterity and use leading legal analytics tools to tackle complex research, deliver quality drafts, and track key issues in the practice of law.
News & Business
News & Business provides customers across industries with news and business information and insights, including company information and U.S. Public Records. Standard products for business research are Nexis and Nexis+ AI, which provide access to over 39,000 licensed sources, including a 45-year news archive across over 50 different languages. Other core products include Nexis Newsdesk for media monitoring, and Nexis Diligence+ for risk assessments.
Nexis+ AI, a generative AI platform designed to transform business research, was launched in 2024. It is built on one of the world’s largest repositories of generative AI licensed news content. Nexis+ AI features powerful research, document summarization, and conversational search features to meet the evolving needs of modern businesses.
Print
Print provides traditional print materials, as well as e-books with case law, statutes, and other primary law sources that include leading brands, such as Matthew Bender, Mealey’s, Michie, LexisNexis A.S. Pratt and LexisNexis Sheshunoff.
Strategic Priorities
LexisNexis is focused on introducing next-generation products and solutions on the Lexis platform and infrastructure; incorporating advanced technologies, including generative AI; driving long-term international growth; and upgrading operational infrastructure, improving process efficiency, and gradually improving margins. Across segments, LexisNexis is focused on the ongoing development of advanced legal research and practice solutions that help lawyers make data-driven decisions with greater accuracy and efficiency. Global functions and presence enable LexisNexis to effectively launch and scale products, such as Lexis+ AI across segments, leveraging shared assets from product design to back-end functionality. LexisNexis is also continuing its mission to advance the Rule of Law around the world through the efforts of the LexisNexis Rule of Law Foundation, a non-profit entity that conducts projects globally to promote transparency of the law, access to legal remedy, equal treatment under the law, and independent judiciaries.
Business Model, Distribution Channels and Competition
LexisNexis Legal & Professional products and services are generally sold directly to law firms and to corporate, government and academic customers on a paid subscription basis, with subscriptions often under multi-year contracts. Principal competitors for LexisNexis in the U.S. legal markets are Westlaw (Thomson Reuters), CCH (Wolters Kluwer), and Bloomberg. In news and business information, key competitors are Bloomberg, Factiva (News Corporation), and Reuters News (Thomson Reuters). Significant international competitors include Thomson Reuters, Wolters Kluwer and Factiva.
Exhibitions segment
Exhibitions (RX) combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products, and complete transactions.
The company helps customers build their businesses through face-to-face events and digital tools, enabling innovation and supporting the economic development of local markets and national economies around the world.
RX has its headquarters in London and has further principal offices in Paris and Düsseldorf in Europe, Norwalk (Connecticut), Mexico City and São Paulo in the Americas, Beijing, Shanghai, Tokyo and Singapore in Asia, and Sydney, Australia. RX’s portfolio serves 41 industry sectors.
In 2024, RX extended the continuous improvement, range and depth of digital and data products offered, increasing their sophistication and the value delivered to customers.
RX organizes influential events in key markets focused on addressing the needs of each particular industry, where participants from around the world meet face-to-face to learn, network, source products or leads, and trade. Its events encompass a wide range of sectors. They include construction, cosmetics, data analytics, electronics, energy and alternative energy, engineering, entertainment, gifts, and jewellery, healthcare, hospitality, interior design, logistics, manufacturing, media, pharmaceuticals, real estate, recreation, security and safety, transport, and travel.
In 2024, RX acquired Sustainable Energy Conferences (SEC), owner of World Hydrogen Summit, expanding its access to the high growth market in renewable and alternative energy through events in three key geographies. During 2024, Exhibitions disposed of a small number of strategically non-core assets in Austria, Australia, and the UK.
Similarly, RX made selective launches to enter new attractive sectors (such as Space Business Expo for space research, Japan) or to extend successful value propositions into new markets (such as Pollutec expanding into Paris, France) or additional calendar slots (such as Japan Food Export Expo into the winter).
Strategic Priorities
RX’s long-term strategic goal is to provide discernible and improving value to buyers and sellers by connecting them to build their businesses, through a mixture of learning, networking, sourcing products or leads, and completing trades. The company delivers this value through a range of market-leading events and digital tools and platforms in all major geographic markets and higher growth sectors. RX focuses on five main areas that position it for long-term success.
Value to customers: RX constantly looks for ways to increase the value generated for customers, by innovating the offering and format of its events, and by deploying digital and data tools and platforms to enhance and extend the face-to-face experience.
Portfolio development: RX continues to actively shape its portfolio through a combination of new launches, strategic partnerships and selective acquisitions, targeting the optimal mix of industry segments, geographic segments, value propositions, and business models.
Best in class go-to-market capabilities: RX continues to drive innovative capabilities in a number of areas critical to its performance, including marketing excellence, sales techniques and the use of analytics to generate insights both for RX and its customers.
Operational efficiency: a lean, nimble structure is in place, able to respond to changing circumstances and customer needs. RX’s global technology platforms and more specialist functions allow RX to accelerate revenue growth, while controlling costs and embedding sustainability throughout the organization. It also enables a faster and more agile deployment of digital products, new events and process innovation.
Talent: RX is a business which supports and creates opportunities for the very best talent, encouraging customer focus, curiosity, and a focus on long-term outcomes.
RX continually enhances the value of its face-to-face events using data, analytics, and technology. RX’s digital solutions help customers to better promote their presence at events, create more connections between the right buyers and sellers, and increase the value of leads generated, thereby demonstrably increasing the return on investment of customer spend at RX events. RX’s digital solutions constantly evolve based on data and deep customer insight about the needs and behaviours of buyers and sellers in the different sectors in which it operates. Underlying the customer experience, RX has developed global technology platforms and a single data lake that allow it to efficiently mine data for insights, and to roll out high quality digital services increasingly quickly across the world, including in 2024 expanding its Colleqt service to help visitors capture their event connections more effectively.
Over 70% of RX’s revenue is derived from exhibitor fees, with the balance primarily consisting of admission charges, conference fees, sponsorship fees and digital tools. RX often works in collaboration with trade associations, which use the events to promote access for members to domestic and export markets, and with governments, for which events can provide important support to stimulate foreign investment and promote regional and national economic activity. RX increasingly offers visitors and exhibitors the opportunity to interact before and after the show using digital tools and platforms, such as online directories, matchmaking, and mobile apps.
RX is one of the largest global event organisers in a fragmented industry, holding a global market share of less than 10%. Other international exhibition organisers include Informa, Clarion and some of the larger German Messen, including Messe Frankfurt, Messe Düsseldorf and Messe Munich.
Strategy
The company’s strategic priority is the organic development of increasingly sophisticated information-based analytics and decision tools that deliver enhanced value to professional and business customers. The company does this by leveraging deep customer understanding to build innovative solutions which combine leading content and data sets with powerful technologies. The company is transforming its core business, building out new products and expanding into higher growth adjacencies and geographies.
The company is supplementing this organic development with selective acquisitions of targeted data sets and analytics, and assets in high-growth markets that support its organic growth strategies and are natural additions to its existing business.
The company’s improving long-term growth trajectory is being driven by the ongoing shift in its business mix towards higher growth analytics and decision tools.
The company’s strategies are to develop increasingly sophisticated information-based analytics and decision tools that deliver enhanced value to professional and business customers across market segments; and primary focus on organic growth, supported by targeted acquisitions.
Research and Development
In 2024, the company spent £464 million in the respect of capitalized development costs.
History
The company was incorporated in 1903. It was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in 2015.
